Afleveringen
-
In this conversation with CMHC Senior Planning Committee Member Pam Taub, MD, future leaders Courtney Bess, MD, MS and Aarthi Thakkar, MD, MPH discuss gaps in current fellowship training in cardiometabolic health, how being part of this program and attending CMHC events has helped them in their training, as well as important takeaways they have been able to apply to patient care.
-
Zijn er afleveringen die ontbreken?
-
Watch Dr. Seth Martin, MD, MHS, discussing the significance of the role of technology and digital health in cardiometabolic risk reduction.
(Recorded October 18, 2023)
-
Watch as CMHC Faculty Pam Taub MD and Ajay Singh MD recapped cardio-renal session at CMHC Annual 2023, where they discussed how cardiologists and nephrologists can work together to tackle cardio-renal diseases, including the latest cardio-renal therapies.
(Recorded October 21, 2023)
-
Watch as CMHC Faculty Christie Ballantyne, MD, Robert Eckel, MD, Erin Michos, MD, Patrick Moriarty, MD, and Paul Ridker, MD, discuss practical pearls about the spectrum of residual ASCVD risk, including:
Inflammation Statin intolerance Elevated triglycerides Lp(a)Recorded October 20, 2023
-
Watch as CMHC faculty Juan Frías, MD and Shivani Agarwal, MD discuss important pearls in the management of type 2 diabetes, including screening for social determinants of health (SDOH), the impact of SDOH on treatment, culturally-sensitive care, as well as the importance of early glycemic control, screening, and GDMT optimization (recorded October 20, 2023).
-
Watch as CMHC faculty Christie Ballantyne, MD, Robert Eckel, MD, Keith Ferdinand, MD, and Anne Peters, MD recap some of the main developments in 2023 across the cardio-renal-metabolic health as discussed at the 18th CMHC Annual meeting, including in obesity, diabetes, dyslipidemia/ASCVD risk, hypertension, and more (recorded October 19, 2023).
-
Watch CMHC co-chairs Christie Ballantyne, MD and Robert Eckel, MD discuss the connections between cardio-renal-metabolic health, and the value of attending the CMCH Annual meeting (recorded October 2023).
-
Vanita Aroda, MD, Associate Professor of Medicine at Harvard Medical School, and Katherine Tuttle, MD, Professor of Medicine at the University of Washington, discuss current disparities in the treatment of women with type 2 diabetes and cardiorenal risk despite the evidence and breadth of available agents. They discuss that women are less likely to receive guideline-directed medical therapy, including both older and newer agents, and less likely to enroll in clinical trials, as well as the need to recognize and address these disparities.
Recorded during 2023 CMHC's Women's Health Masterclass, August 19, 2023.
-
2023 CMHC's Women's Health Masterclass Co-Chairs Erin Michos, MD and Pam Taub, MD recap the obesity & lifestyle sessions, and in conversation with Fatima Rodriguez, MD, discuss practical pearls for the management of obesity in women across the lifespan, including the synergy between lifestyle interventions and pharmacotherapy, and how to facilitate the dialogue in patients with overweight and obesity to improve overall cardiovascular risk.
Recorded during 2023 CMHC's Women's Health Masterclass, August 18, 2023.
-
Rachel Bond, MD, System Director of the Women's Heart Health Program at Dignity Health in AZ, has a conversation with Chrisandra Shufelt, MD, Professor of Medicine at Mayo Clinic in FL, about unique cardiometabolic risk factors in women. They discuss the impact of adverse pregnancy outcomes across the lifespan and changes associated with the menopause transition on overall cardiometabolic risk assessment, as well as important clinical pearls in this setting.
Recorded during 2023 CMHC's Women's Health Masterclass, August 18, 2023.
-
Brittany Weber, MD, PhD, Director of the Cardio-Rheumatology Clinical at Brigham and Women's Hospital, discusses the role of systemic inflammation in promoting cardiovascular risk, the link between systemic inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, and others) and cardiovascular adverse events, and how cardiologists and rheumatologists can work together to manage patients with these comorbid conditions.
Recorded at 2023 CMHC Spring, May 19, 2023
-
During this interview, Jennifer Green, MD, Professor of Medicine at Duke, discusses the multimorbidity in patients with type 2 diabetes, the role of inflammation as a driver of multimorbidity in this setting, as well as practical pearls for the utilization of newer cardio-renal protective agents in these patients.
Recorded at 2023 CMHC Spring, May 20, 2023
-
CMHC Co-Chair George Bakris, MD, Professor of Medicine at University of Chicago, reviews the association between inflammation and hypertension, as well as provides important clinical pearls for the management of hypertension and how to best utilize the existing treatment options.
Recorded May 19, 2023.
-
CMHC Faculty, Ileana Piña, MD, Professor of Medicine Thomas Jefferson University, discusses the connections between inflammation and heart failure, trials looking at targeting inflammation in this setting, and the importance of shared decision-making in treating patients with heart failure.
Recorded on May 19, 2023.
-
Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum
Episode 3: A Patient with Sleep Apnea & Comorbidities
with Virend Somers, MD, PhD, Deborah Clegg, PhD, RD, and Gregg Pressman, MD, FACC, FASE
In this 3-part podcast series, Virend Somers, MD, PhD, Professor at the Department of Cardiovascular Medicine at Mayo Clinic moderates discussions with Deborah Clegg, PhD, RD, Professor of Internal Medicine at Texas Tech University and Gregg Pressman, MD, FACC, FASE, Professor of Medicine at Thomas Jefferson University on salt, sleep, and how these relate to increased cardiovascular risk. They discuss the risk of increased sodium intake in patients with CVD or at CVD risk, including in patients with sleep disorders, as well as practical strategies to minimize the impact of elevated sodium.
Recorded May 4, 2023.
-
Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum
Episode 2: Sodium as a Driver of Cardiovascular and Cardiometabolic Risk
with Virend Somers, MD, PhD, Deborah Clegg, PhD, RD, and Gregg Pressman, MD, FACC, FASE
In this 3-part podcast series, Virend Somers, MD, PhD, Professor at the Department of Cardiovascular Medicine at Mayo Clinic moderates discussions with Deborah Clegg, PhD, RD, Professor of Internal Medicine at Texas Tech University and Gregg Pressman, MD, FACC, FASE, Professor of Medicine at Thomas Jefferson University on salt, sleep, and how these relate to increased cardiovascular risk. They discuss the risk of increased sodium intake in patients with CVD or at CVD risk, including in patients with sleep disorders, as well as practical strategies to minimize the impact of elevated sodium.
Recorded May 4, 2023.
- Laat meer zien